Case Report: A rare case of biopsy-proven lupus nephritis complicated by Graves’ disease in a 39-year-old man

Hyperthyroidism and systemic lupus erythematosus (SLE) are both common diseases in internal medicine. Among them, Graves’ disease (GD) is the most frequent cause of hyperthyroidism, while lupus nephritis (LN) represents one of the most severe organ manifestations of SLE. Basic research suggests that GD and SLE may share overlapping genetic and immunological pathways; however, whether these shared mechanisms contribute to their clinical coexistence remains uncertain. Clinical studies or case reports on their coexistence are currently limited, and we cannot effectively manage cases of co-occurrence based on authoritative guidelines or expert consensus. In this study, we report a 39-year-old male patient with biopsy-proven ISN/RPS Class IV + V LN concomitant with GD. The patient was treated with a combination of glucocorticoids, mycophenolate mofetil, and hydroxychloroquine for LN, along with methimazole for GD, supplemented by symptomatic therapy including antihypertensive and heart rate controlling agents, etc. The patient demonstrated early clinical and laboratory improvement during follow-up, although the limited follow-up precluded assessment of an established renal response.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-10-28
DOI
https://doi.org/10.3389/fimmu.2026.1908289
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: A rare case of biopsy-proven lupus nephritis complicated by Graves’ disease in a 39-year-old man

张蓓茹, Xiaoguang Shi, Mi Tian, Xichang Wang
1 links
Frontiers in Immunology
Systemic Lupus Erythematosus Research
article

Case Report: A rare case of biopsy-proven lupus nephritis complicated by Graves’ disease in a 39-year-old man

张蓓茹, Xiaoguang Shi, Mi Tian, Xichang Wang
article en

Abstract

Hyperthyroidism and systemic lupus erythematosus (SLE) are both common diseases in internal medicine. Among them, Graves’ disease (GD) is the most frequent cause of hyperthyroidism, while lupus nephritis (LN) represents one of the most severe organ manifestations of SLE. Basic research suggests that GD and SLE may share overlapping genetic and immunological pathways; however, whether these shared mechanisms contribute to their clinical coexistence remains uncertain. Clinical studies or case reports on their coexistence are currently limited, and we cannot effectively manage cases of co-occurrence based on authoritative guidelines or expert consensus. In this study, we report a 39-year-old male patient with biopsy-proven ISN/RPS Class IV + V LN concomitant with GD. The patient was treated with a combination of glucocorticoids, mycophenolate mofetil, and hydroxychloroquine for LN, along with methimazole for GD, supplemented by symptomatic therapy including antihypertensive and heart rate controlling agents, etc. The patient demonstrated early clinical and laboratory improvement during follow-up, although the limited follow-up precluded assessment of an established renal response.

Frontiers in ImmunologyVol. 17
Sheng Jing Hospital (CN), China Medical University (CN)
Good health and well-being
Openalex Percentile: Top 12%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon